LDL-C LOWERING AMONG PATIENTS WITH LDL-C ABOVE 4.9 MMOL/L AND FEATURES SUGGESTING A GENETIC VULNERABILITY TO CARDIOVASCULAR DISEASE: ANALYSES FROM THE 4S TRIAL

A. J. Vallejo-Vaz, C. J. Packard, B. A. Ference, R. D. Santos, J. J. Kastelein, E. A. Stein, A. L. Catapano, T. R. Pedersen, G. F. Watts, K. K. Ray

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)E6-E6
Number of pages1
JournalAtherosclerosis
Volume287
DOIs
Publication statusPublished - Aug 2019
Event87th Congress of the European Atherosclerosis Society (EAS) - Maastricht, Netherlands
Duration: 26 May 201929 May 2019
https://eas2019.com/

Cite this

Vallejo-Vaz, A. J., Packard, C. J., Ference, B. A., Santos, R. D., Kastelein, J. J., Stein, E. A., Catapano, A. L., Pedersen, T. R., Watts, G. F., & Ray, K. K. (2019). LDL-C LOWERING AMONG PATIENTS WITH LDL-C ABOVE 4.9 MMOL/L AND FEATURES SUGGESTING A GENETIC VULNERABILITY TO CARDIOVASCULAR DISEASE: ANALYSES FROM THE 4S TRIAL. Atherosclerosis, 287, E6-E6. https://doi.org/10.1016/j.atherosclerosis.2019.06.016